Calidar Completes First-in-Human Study of Eidos Prism™ and Advances Toward 2027 Pivotal Study

Wait 5 sec.

The company targets five to seven sites for its pivotal study spanning rural/community health systems, large academic medical centers, and independent imaging centers across the country. RESEARCH TRIANGLE PARK, N.C., Aug. 12, 2026 /PRNewswire/ -- Calidar, Inc. today announced the...